Calidi Biotherapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2022 | $-13.2M | $-13.2M | — | $4.5M |
| FY2023 | $-27.0M | $-27.0M | — | $4.8M |
| FY2024 | $-19.7M | $-19.7M | — | $3.0M |
| FY2025 | $-21.3M | $-21.3M | — | $2.1M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2022 | $-13.2M | $-13.2M | — | $4.5M |
| FY2023 | $-27.0M | $-27.0M | — | $4.8M |
| FY2024 | $-19.7M | $-19.7M | — | $3.0M |
| FY2025 | $-21.3M | $-21.3M | — | $2.1M |